US 8877917
Glycoconjugates of RNA interference agents
granted A61KA61K31/713A61K47/549
Quick answer
US patent 8877917 (Glycoconjugates of RNA interference agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/713, A61K47/549, A61K47/60